Related Experiment Video
Updated: Mar 27, 2026

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
16.5K
Machine learning on Parkinson's disease? Let's translate into clinical practice.
1IBFM, National Research Council, Viale Europa, Catanzaro, 88100, Italy.
Journal of Neuroscience Methods
|January 9, 2016
Summary
Machine learning in neuroimaging offers advanced prediction for neurological disorders. While promising for Parkinson
Area of Science:
- Neuroimaging
- Machine Learning
- Neurological Disorders
Background:
- Clinical neuroimaging traditionally focuses on anatomical changes in neurological disorders.
- Machine learning (ML) represents a shift towards predictive analysis in this field.
Purpose of the Study:
- To evaluate the potential of multivariate machine learning approaches in classifying neurological disorders.
- To assess the predictive capabilities of ML using neuroimaging data for unseen patient cohorts.
Main Methods:
- Application of machine learning techniques to clinical neuroimaging data.
- Multivariate analysis of neuroimaging abnormalities for classification.
Main Results:
- Machine learning enables a predictive approach in neuroimaging, moving beyond anatomical descriptions.
- The study explores the potential of ML in classifying previously unseen clinical cohorts.
Conclusions:
- Machine learning is poised to significantly impact the clinical practice of Parkinson's disease.
- Important barriers must be addressed before widespread adoption of ML in clinical neuroimaging for Parkinson's disease.
Related Concept Videos
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview
2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K

